XBIT vs. XBI
Compare and contrast key facts about XBiotech Inc. (XBIT) and SPDR S&P Biotech ETF (XBI).
XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: XBIT or XBI.
Correlation
The correlation between XBIT and XBI is 0.32, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
XBIT vs. XBI - Performance Comparison
Key characteristics
XBIT:
-0.19
XBI:
-0.16
XBIT:
0.34
XBI:
-0.05
XBIT:
1.04
XBI:
0.99
XBIT:
-0.19
XBI:
-0.08
XBIT:
-0.55
XBI:
-0.47
XBIT:
29.18%
XBI:
8.60%
XBIT:
85.72%
XBI:
25.25%
XBIT:
-92.67%
XBI:
-63.89%
XBIT:
-86.33%
XBI:
-50.10%
Returns By Period
In the year-to-date period, XBIT achieves a -6.08% return, which is significantly lower than XBI's -3.78% return.
XBIT
-6.08%
-46.62%
-43.45%
-25.80%
-29.70%
N/A
XBI
-3.78%
-7.21%
-14.90%
-4.02%
-2.18%
2.95%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
XBIT vs. XBI — Risk-Adjusted Performance Rank
XBIT
XBI
XBIT vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for XBiotech Inc. (XBIT) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
XBIT vs. XBI - Dividend Comparison
XBIT has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.15%.
TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
XBiotech Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 22.46% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPDR S&P Biotech ETF | 0.15% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% |
Drawdowns
XBIT vs. XBI - Drawdown Comparison
The maximum XBIT drawdown since its inception was -92.67%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for XBIT and XBI. For additional features, visit the drawdowns tool.
Volatility
XBIT vs. XBI - Volatility Comparison
XBiotech Inc. (XBIT) has a higher volatility of 40.25% compared to SPDR S&P Biotech ETF (XBI) at 8.03%. This indicates that XBIT's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.